High-Waist Knee-Length Leggings
High-waist, anti-cellulite, knee-length leggings
shipments in 4 days
edematous fibrosclerotic panniculopathy & cellulite
The high-waist, knee-length leggings use electromagnetotherapy to promote cellular biostimulation and reactivate the body’s microcirculation. The slimming leggings help to:
- Reactivate microcirculation
- Drain excess fluids
- Reduce swelling
FIT - The Spike-Cell anti-cellulite knee-length leggings are soft, supple and adhere perfectly to the body, allowing full freedom of movement.
MAXIMUM COMFORT - Made from highly technological yarns, the knee-length leggings are soft in contact with the skin, perfect for wearing under all types of clothing, even tight-fitting clothes, and create the effect of a flat stomach and shaped buttocks. They do not cause excess sweating, itching or any burning sensation.
AN ALLY AGAINST IMPERFECTIONS - The anatomical shape adheres perfectly to the skin and reactivates microcirculation via body heat.
Made with the innovative Spike yarn, the leggings generate constant biostimulating microcurrents that help improve microcirculation and the draining of excess liquids and fats. Used for long periods of time, they help reduce cellulite on the abdomen, hips, buttocks and thighs.
HOW TO USE - The knee-length slimming leggings should be worn in contact with the skin for a minimum of 8 hours a day. It is recommended to not wear underwear during the anti-cellulite treatment. To wear correctly, first, roll them up and gently unroll them onto the body without over-stretching the fabric, and aim to position the logo on the back side of the right leg.
The use of Spike-Cell products should be avoided if you are pregnant, have a pacemaker or other active implantable devices. At the beginning of the treatment, you may feel a slight tingling sensation, due to the microcurrents generated by the product.
AUTHORIZATION - CELL 460 CORSARO BODYSYUT is a medical device approved by the Italian Ministry of Health pursuant to Article 21 of Legislative Decree 24th February 1997, No. 46. Implementation of Directive 93/4/EEC concerning medical devices.
other products that may interest you